PHAT Stock-Based Compensation
Phathom Pharmaceuticals Inc · Stock-Based Compensation
PHAT Stock-Based Compensation
Latest reported$27.15Mperiod ending
PHAT TTM Stock-Based Comp ($0.00 → $27.15M)
TTM stock-based compensation
High-resolution chart · PNG
PHAT stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 27,153,000 | |
| 28,713,000 | |
| 28,719,000 | |
| 29,796,000 | |
| 26,134,000 | |
| 23,961,000 | |
| 24,047,000 | |
| 41,944,000 | |
| 42,449,000 | |
| 43,603,000 | |
| 45,025,000 | |
| 27,098,000 | |
| 26,774,000 | |
| 25,406,000 | |
| 24,133,000 | |
| 21,814,000 | |
| 20,417,000 | |
| 18,769,000 | |
| 16,812,000 | |
| 14,853,000 | |
| 12,504,000 | |
| 9,095,000 | |
| 5,840,000 | |
| 3,801,000 | |
| 1,768,000 | |
| 969,000 | |
| 406,000 | |
| 66,000 | |
| 29,000 | |
| 0 | |
| 0 |